U.S. futures dip; Black Friday spending surge - what’s moving markets
Aftab Dana, Executive Vice President, Research and Development at EXELIXIS, INC. (NASDAQ:EXEL), sold 48,383 shares of common stock on November 11, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $42.50, resulting in a total transaction value of approximately $2.05 million. The prices for the sale ranged from $42.50 to $42.58. Despite this insider sale, InvestingPro data shows the stock is currently trading below its Fair Value, with management actively buying back shares.
Following the transaction, Aftab Dana directly owns 664,778 shares of Exelixis common stock, which includes 431,306 shares that will be issued upon the vesting of restricted stock units. Additionally, Aftab Dana indirectly owns 5,835 shares of common stock through the Exelixis, Inc. 401(k) Plan. Exelixis maintains an "Excellent" financial health rating according to InvestingPro, with a PEG ratio of just 0.32 and a robust 96.6% gross profit margin. Discover 11 more exclusive ProTips and comprehensive analysis in the Pro Research Report.
In other recent news, Exelixis reported robust financial results for the third quarter of 2025, with total revenue reaching $597.8 million. This figure surpassed both Oppenheimer’s estimate of $584.0 million and the consensus forecast of $590.2 million. The company also posted earnings per share of $0.78, exceeding the expected $0.69. Despite these positive earnings and revenue results, Oppenheimer maintained its Perform rating on Exelixis with a price target of $36.00. These developments reflect ongoing investor interest and analyst evaluation of the company’s performance. Exelixis’ recent financial outcomes indicate strong operational execution, as evidenced by the earnings and revenue surpassing projections. However, the stock’s movement in regular and after-hours trading suggests a mixed response from investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.